StartseiteEU funds “NeutroCure” with 3 Mio. Euros
A drug is being developed at FAU which controls the concentration of oxygen radicals in immune cells, and could revolutionise treatment of inflammatory diseases or even cancer. The ‘NeutroCure’ project has received funding of approximately three million euros from the European Union as part of the Horizon 2020 programme. Speaker of the project is Prof. […]A drug is being developed at FAU which controls the concentration of oxygen radicals in immune cells, and could revolutionise treatment of inflammatory diseases or even cancer. The ‘NeutroCure’ project has received funding of approximately three million euros from the European Union as part of the Horizon 2020 programme. Speaker of the project is Prof. […]
